Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 56.47% |
| 2 | Technology | 8.38% |
| 3 | Healthcare | 7.46% |
| 4 | Consumer Discretionary | 5.14% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
Mercury Insurance
MCY
$5.69B
| $5.83M | ﹤0.01% |
192,665
-251,942
| -57% | -$7.69M |
|
|
DAWN
2477
DELISTED
Day One Biopharmaceuticals
DAWN
| $5.83M | ﹤0.01% |
488,124
+268,454
| +122% | +$3.51M |
|
2478
Oportun Financial
OPRT
$344M
| $5.82M | ﹤0.01% |
975,696
+520,609
| +114% | +$2.56M |
|
2479
Digi International
DGII
$2.94B
| $5.82M | ﹤0.01% |
147,696
-26,546
| -15% | -$913K |
|
2480
CALL
Cintas
CTAS
$81.7B
| $5.82M | ﹤0.01% |
46,800
+40,800
| +680% | +$4.79M |
|
2481
Unisys
UIS
$198M
| $5.81M | ﹤0.01% |
1,459,715
-925,807
| -39% | -$3.67M |
|
|
AXON
2482
Axon Enterprise
AXON
$49.7B
| $5.81M | ﹤0.01% |
29,767
-61,753
| -67% | -$12.8M |
|
2483
Riot Platforms
RIOT
$7.84B
| $5.81M | ﹤0.01% |
491,359
+414,794
| +542% | +$4.64M |
|
2484
Lightwave Logic
LWLG
$905M
| $5.81M | ﹤0.01% |
833,260
+822,397
| +7,571% | +$4.78M |
|
2485
Douglas Elliman
DOUG
$169M
| $5.8M | ﹤0.01% |
+2,614,800
| New | +$7.18M |
|
2486
Rigel Pharmaceuticals
RIGL
$875M
| $5.8M | ﹤0.01% |
449,576
-74,136
| -14% | -$1M |
|
|
NOTE
2487
DELISTED
FiscalNote
NOTE
| $5.8M | ﹤0.01% |
132,745
+82,775
| +166% | +$2.32M |
|
2488
BHP
BHP
$245B
| $5.79M | ﹤0.01% |
97,065
+93,065
| +2,327% | +$5.55M |
|
2489
PUT
Celanese
CE
$4.92B
| $5.79M | ﹤0.01% |
+50,000
| New | +$5.42M |
|
2490
Community Trust Bancorp
CTBI
$1.39B
| $5.78M | ﹤0.01% |
162,503
+94,998
| +141% | +$3.42M |
|
2491
CALL
Chubb
CB
$131B
| $5.78M | ﹤0.01% |
30,000
-12,800
| -30% | -$2.51M |
|
2492
Aurora
AUR
$11.4B
| $5.78M | ﹤0.01% |
1,964,547
-2,571,193
| -57% | -$4.31M |
|
2493
PUT
Iron Mountain
IRM
$36.5B
| $5.77M | ﹤0.01% |
101,600
-18,800
| -16% | -$1.03M |
|
|
DNAB
2494
DELISTED
Social Capital Suvretta Holdings Corp. II Class A Ordinary Shares
DNAB
| $5.76M | ﹤0.01% |
556,865
| – | – |
|
2495
Darden Restaurants
DRI
$24B
| $5.76M | ﹤0.01% |
34,469
-196,486
| -85% | -$30.9M |
|
2496
PUT
Alcon
ALC
$34.9B
| $5.75M | ﹤0.01% |
70,000
+45,000
| +180% | +$3.44M |
|
2497
CALL
HSBC
HSBC
$352B
| $5.74M | ﹤0.01% |
+145,000
| New | +$5.41M |
|
2498
Endava
DAVA
$174M
| $5.74M | ﹤0.01% |
110,882
+1,298
| +1% | +$69.8K |
|
2499
Brunswick
BC
$5.03B
| $5.73M | ﹤0.01% |
66,149
+59,966
| +970% | +$4.89M |
|
2500
iShares Core US Aggregate Bond ETF
AGG
$139B
| $5.73M | ﹤0.01% |
+58,456
| New | +$5.78M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander's Q2 2023 filing shows 870 new, 2,213 increased, 2,337 reduced and 1,192 closed positions. Its largest new stake was ResMed: 632,015 shares worth $138M. The largest sale was Tesla, an estimated $491M.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.